Single-center, Open-label, Randomized 2-way Crossover Study of the Effect of Lacosamide 200 mg Twice Daily on the Single-dose Pharmacokinetics and Pharmacodynamics of Warfarin (25 mg) in Healthy Male Volunteers.

Trial Profile

Single-center, Open-label, Randomized 2-way Crossover Study of the Effect of Lacosamide 200 mg Twice Daily on the Single-dose Pharmacokinetics and Pharmacodynamics of Warfarin (25 mg) in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Lacosamide (Primary) ; Warfarin
  • Indications Epilepsy; Fibromyalgia; Osteoarthritis; Pain; Thromboembolism
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.
    • 04 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top